Suzannah K. Sundby is the Managing Partner of the Washington, DC office of Canady + Lortz LLP.
Washington, DCsuzannah@canadylortz.com
Suzannah practices all aspects of intellectual property law across a diverse array of technological fields including biochemistry, molecular biology, recombinant technologies, small molecules, pharmaceuticals, biologics, vaccines, microfluidics, diagnostics, medical devices and treatments, orphan drugs, catalyst compositions, and nanotechnology. Suzannah’s legal practice involves patent preparation and prosecution, licensing, opinion work, post-grant proceedings, strategic planning, and client counseling. She also assists start-up biotech companies with the preparation and prosecution of their foundation patents, non-disclosure agreements, and related IP issues.
Suzannah is a 2019 recipient of an Alumni Distinguished Achievement Award from her alma mater—The University of Wisconsin, Eau Claire—where she received her degree in biochemistry and molecular biology.
Suzannah is among a select few experts listed in the Life Sciences Expert Guide. She is ranked as an Intellectual Property Life Sciences Star in the LMG Life Sciences Guide, and on several occasions has been recognized on the Patent Strategy & Management Attorney of the Year – District of Columbia shortlists. She is also ranked as a Patent Star in the IP Stars handbook published by Managing Intellectual Property.
Suzannah was the Chair of the Biotechnology Committee of the American Intellectual Property Law Association (AIPLA) for the 2013–2015 term and a member of AIPLA’s Task Force Committee on 101 Eligibility from 2014–2017. She was an Adjunct Professor at Franklin Pierce Law Center and taught Advanced Biotech Patent Preparation and Prosecution.
Before entering the legal field, Suzannah was a cytogeneticist and helped map the Drosophila genome as a member of the University of California’s Berkeley Drosophila Genome Group.
Education
- Franklin Pierce Law Center, JD
- Franklin Pierce Law Center, Masters in IP Law
- University of Wisconsin – Eau Claire, BS in Biochemistry/Molecular Biology
Admissions
- California Bar
- District of Columbia Bar
- United States Court of Appeals for the Federal Circuit
- United States Northern, Eastern, & Southern District Courts of California
- United States Patent & Trademark Office
- Supreme Court of the United States
Professional Associations
- American Intellectual Property Law Association
- American Association for the Advancement of Science
Selected Presentations
- Workshop Leader, “Responding to Office Actions – Biotech/Pharma/Chemical”, AIPLA Prosecution Boot Camp, Philadelphia, PA, May 2019
- Panelist, “IP Expert Panel – Current IP issues”, National Association of Patent Practitioners Annual Meeting, USPTO, Alexandria, VA, July 2019
- Workshop Leader, “Responding to Office Actions – Biotech/Pharma/Chemical”, AIPLA Prosecution Boot Camp, Denver, CO, February 2018
- Speaker, “Examining Examiners: I Say Potato and You Say Vegetable – BRI and Unexpected Results of Interviews”, AIPLA Annual Meeting, Washington, DC, October 2017
- Speaker, “Lessons from Trailblazers”, Young Women in Bio Spring into STEM Event, Rockville, MD, April 2017
- Speaker, “101 Guidelines & Case Law in Biotech & Precision Medicine”, AIPLA Webinar, January 2017
- Invited Public Speaker, “Eligibility of Weighted and Combination Diagnostic Assays”, USPTO Forum on Interim Eligibility Guidance, January 2015
- Invited Speaker, “Compacting Prosecution by Interviews: A View From Outside the USPTO,” presented to the USPTO Examiner Corps by invitation of Director David Kappos, February 2011
Representative Patents
- US 10,196,458 Anti-Immunoglobulin E Antibodies and Methods of Using Thereof
- US 10,166,277 Vault Immunotherapy
- US 10,086,061 Combination Purified Inactivated Vaccine for Flaviviruses
- US 9,951,118 Engineering Antiviral T Cell Immunity through Stem Cells and Chimeric Antigen Receptors
- US 9,700,562 Triazine Compounds and Methods for Treating Malaria
- US 9,555,090 Equine Encephalitis Virus Vaccines
- US 9,133,253 Ricin vaccine and methods of making thereof
- US 8,647,633 Recombinant F1-V plague vaccine
- US 8,435,941 Mini-hepcidin peptides and methods of using thereof
- US 7,825,154 Small molecule inhibitors of botulinum neurotoxins